Form 8-K · Current report

Philip Morris International 8-K, filed Sep 8, 2026

Filed
CIK
0001413329
Accession no.
0001628280-26-060822
AI-generated summary

Summary

Philip Morris International raised its 2026 adjusted diluted EPS forecast to $8.35–$8.50, or 10.7%–12.7% growth, on a 24-cent favorable currency effect, with Group CEO Jacek Olczak presenting at the Barclays Global Consumer Conference. PMI said IQOS is driving broad-based smoke-free growth, including a Japan consumer offtake recovery in line with expectations, and that it is expanding its U.S. ZYN range.

Key points

  • PMI's 2026 adjusted diluted EPS forecast was raised for currency only to $8.35–$8.50, and includes a Q3 forecast of $2.29–$2.34 with 1 cent favorable currency.
  • PMI said Japan IQOS consumer offtake recovery is in line with expectations and October pricing is confirmed.
  • PMI reported strong multicategory growth in international markets including VEEV and ZYN.
  • PMI will transition the 3mg and 6mg dry ZYN variants to 20 pouches per can in Q4 as part of expanding the U.S. ZYN range.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 7.01Regulation FD Disclosure
  • 9.01Financial Statements and Exhibits

From the filing

Item 7.01. Regulation FD Disclosure. On September 8, 2026, Philip Morris International Inc. (“PMI”) is hosting a live audio webcast of a presentation and question-and-answer session by Jacek Olczak, Group CEO PMI, at the Barclays Global Consumer Conference. In connection with the webcast, PMI is furnishing to the Securities and Exchange Commission the webcast slides attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference into this Item 7.01. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Philip Morris International in Readster

Add Philip Morris International to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.